SCHEMBL4355457

SCHEMBL4355457

O=C(Nc1c[nH]nc1C(=O)O)c1cccc(Cl)c1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 2/20 0.50
TSHR P16473 1/20 0.47
GPR35 Q9HC97 1/20 0.46
JAK1 P23458 1/20 0.46
MAOB P27338 1/20 0.44
GAA P10253 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
TP53 P04637 1/20 0.43
HPGD P15428 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C19 P33261 1/20 0.43
P2RX7 Q99572 1/20 0.43
ANO1 Q5XXA6 1/20 0.42
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
TAS1R2 Q8TE23 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL954955 0.85 KMT2A (0.51) JAK2JAK1RAB9AMEN1KMT2A
SCHEMBL5006782 0.81 TTR (0.47) JAK2JAK1GAAMEN1KMT2A
SCHEMBL4488401 0.81 CDK14 (0.48) JAK2JAK1MEN1KMT2ACDK14
SCHEMBL8219606 0.80 TYK2 (0.52) RAB9AMEN1KMT2ACDK14CCNY
SCHEMBL1645592 0.80 JAK2 (0.52) JAK2JAK1MAOBGAASMN1; SMN2
SCHEMBL2800923 0.78 CSF1R (0.53) SMN1; SMN2TP53HPGDNPC1RAB9A
SCHEMBL2804529 0.78 L3MBTL1 (0.52) GAASMN1; SMN2NPC1RAB9AMEN1
SCHEMBL5007605 0.78 CDK14 (0.46) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL8219073 0.77 P2RX7 (0.51) GAAP2RX7MEN1KMT2ABDKRB1
SCHEMBL1645416 0.77 CNR1 (0.48) SMN1; SMN2TP53MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046327-A1 MEDICAL USE OF CYCLIN DEPENDENT KINASES INHIBITORS Astex Therapeutics Limited (GB) 2009-04-15 EP disclosed
EP-2027109-A1 4- (2, 6-DICHLORO-BENZOYLAMINO) -1H-PYRAZOLE-S-CARBOXYLIC ACID (1-METHANESULPH0NYL-PIPERIDIN-4-YL) -AMIDE FOR THE TREATMENT OF CANCER Astex Therapeutics Limited (GB) 2009-02-25 EP disclosed
WO-2008009954-A1 MEDICAL USE OF CYCLIN DEPENDENT KINASES INHIBITORS ASTEX THERAPEUTICS LIMITED (GB) 2008-01-24 WO disclosed
WO-2007129066-A1 4- (2,6-DICHLORO-BENZOYLAMINO) -1H-PYRAZOLE-3-CARBOXYLIC ACID (1-METHANESULPHONYL-PIPERIDIN-4-YL) -AMIDE FOR THE TREATMENT OF CANCER ASTEX THERAPEUTICS LIMITED (GB) 2007-11-15 WO disclosed